{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:41:42Z","timestamp":1792827702934,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008220","name":"Bracco Imaging Ltd.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008220","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.euo.2025.07.001","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T11:23:40Z","timestamp":1753442620000},"page":"320-327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Fast Biparametric Versus Multiparametric Magnetic Resonance Imaging for Triage of Men with Elevated Prostate-specific Antigen: The PRO-TRIAGE Prospective Comparative Trial"],"prefix":"10.1016","volume":"9","author":[{"given":"Hyungwoo","family":"Ahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Yeon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong In","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bumjin","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Soo","family":"Kyung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bokyung","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Mee","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Gab","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kye Jin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2025.07.001_b0005","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1056\/NEJMoa1910038","article-title":"MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis","volume":"382","author":"Ahdoot","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2025.07.001_b0010","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJMoa2100852","article-title":"MRI-targeted or standard biopsy in prostate cancer screening","volume":"385","author":"Eklund","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2025.07.001_b0015","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa2406050","article-title":"Results after four years of screening for prostate cancer with PSA and MRI","volume":"391","author":"Hugosson","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2025.07.001_b0020","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jamaoncol.2020.7456","article-title":"Population-based prostate cancer screening with magnetic resonance imaging or ultrasonography: the IP1-PROSTAGRAM study","volume":"7","author":"Eldred-Evans","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.euo.2025.07.001_b0025","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S1470-2045(21)00348-X","article-title":"Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial","volume":"22","author":"Nordstr\u00f6m","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euo.2025.07.001_b0030","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(18)30569-2","article-title":"Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study","volume":"20","author":"Rouvi\u00e8re","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euo.2025.07.001_b0035","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.euo.2025.07.001_b0040","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2025.07.001_b0045","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate Imaging Reporting and Data System version 2.1: 2019 update of Prostate Imaging Reporting and Data System version 2","volume":"76","author":"Turkbey","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.07.001_b0050","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2214\/AJR.23.29011","article-title":"Beyond the AJR: biparametric MRI-based prostate cancer screening-a cost-effective alternative to PSA screening and standard biopsy","volume":"221","author":"Ward","year":"2023","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.euo.2025.07.001_b0055","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.eururo.2020.03.002","article-title":"Additional value of dynamic contrast-enhanced sequences in multiparametric prostate magnetic resonance imaging: data from the PROMIS study","volume":"78","author":"Bosaily","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.07.001_b0060","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.eururo.2019.05.029","article-title":"High diagnostic performance of short magnetic resonance imaging protocols for prostate cancer detection in biopsy-naive men: the next step in magnetic resonance imaging accessibility","volume":"76","author":"van der Leest","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.07.001_b0065","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.euo.2021.03.007","article-title":"Diagnostic accuracy of single-plane biparametric and multiparametric magnetic resonance imaging in prostate cancer: a randomized noninferiority trial in biopsy-naive men","volume":"4","author":"Russo","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.07.001_b0070","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.54577","article-title":"Repeated prostate cancer screening using prostate-specific antigen testing and magnetic resonance imaging: a secondary analysis of the STHLM3-MRI randomized clinical trial","volume":"7","author":"Nordstr\u00f6m","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.euo.2025.07.001_b0075","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0219","article-title":"Assessment of the diagnostic accuracy of biparametric magnetic resonance imaging for prostate cancer in biopsy-naive men: the Biparametric MRI for Detection of Prostate Cancer (BIDOC) study","volume":"1","author":"Boesen","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.euo.2025.07.001_b0080","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1007\/s00261-021-03011-0","article-title":"Susceptibility artifacts and PIRADS 3 lesions in prostatic MRI: how often is the dynamic contrast-enhance sequence necessary?","volume":"46","author":"Antunes","year":"2021","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.euo.2025.07.001_b0085","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1016\/j.crad.2023.11.026","article-title":"Benefit of dynamic contrast-enhanced (DCE) imaging for prostate cancer detection depending on readers experience in prostate MRI","volume":"79","author":"Ziayee","year":"2024","journal-title":"Clin Radiol"},{"key":"10.1016\/j.euo.2025.07.001_b0090","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.eururo.2020.04.062","article-title":"Can biparametric prostate magnetic resonance imaging fulfill its PROMIS?","volume":"78","author":"de Rooij","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.07.001_b0095","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S1474-4422(17)30158-8","article-title":"Gadolinium deposition in the brain: summary of evidence and recommendations","volume":"16","author":"Gulani","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.euo.2025.07.001_b0100","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.euo.2019.08.008","article-title":"Prebiopsy IMPROD biparametric magnetic resonance imaging combined with prostate-specific antigen density in the diagnosis of prostate cancer: an external validation study","volume":"3","author":"Knaapila","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.07.001_b0105","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/jmri.28142","article-title":"Comparison of multiparametric and fast MRI protocols in detecting clinically significant prostate cancer and a detailed cost analysis","volume":"56","author":"Alver","year":"2022","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.euo.2025.07.001_b0110","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/jamaoncol.2022.5252","article-title":"Cost-effectiveness of prostate cancer screening using magnetic resonance imaging or standard biopsy based on the STHLM3-MRI study","volume":"9","author":"Hao","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.euo.2025.07.001_b0115","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s41391-020-00298-w","article-title":"A systematic review and meta-analysis of the diagnostic accuracy of biparametric prostate MRI for prostate cancer in men at risk","volume":"24","author":"Bass","year":"2021","journal-title":"Prostate Cancer Prostat Dis"},{"key":"10.1016\/j.euo.2025.07.001_b0120","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.eururo.2024.09.035","article-title":"Evaluating biparametric versus multiparametric magnetic resonance imaging for diagnosing clinically significant prostate cancer: an international, paired, noninferiority, confirmatory observer study","volume":"87","author":"Twilt","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.07.001_b0125","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.231383","article-title":"Comparison of positive predictive values of biparametric MRI and multiparametric MRI-directed transrectal US-guided targeted prostate biopsy","volume":"311","author":"Schieda","year":"2024","journal-title":"Radiology"},{"key":"10.1016\/j.euo.2025.07.001_b0130","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1148\/radiol.2017170129","article-title":"Abbreviated biparametric prostate MR imaging in men with elevated prostate-specific antigen","volume":"285","author":"Kuhl","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.euo.2025.07.001_b0135","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.euo.2025.07.001_b0140","doi-asserted-by":"crossref","first-page":"8692","DOI":"10.1007\/s00330-021-07907-9","article-title":"Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the G\u00f6teborg prostate cancer screening 2 trial","volume":"31","author":"Wallstr\u00f6m","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.euo.2025.07.001_b0145","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/JU.0000000000001200","article-title":"Interreader agreement with Prostate Imaging Reporting and Data System version 2 for prostate cancer detection: a systematic review and meta-analysis","volume":"204","author":"Park","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.07.001_b0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.euo.2020.02.005","article-title":"Factors influencing variability in the performance of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer: a systematic literature review","volume":"3","author":"Stabile","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.07.001_b0155","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.euo.2018.09.001","article-title":"Prebiopsy biparametric magnetic resonance imaging combined with prostate-specific antigen density in detecting and ruling out Gleason 7\u201310 prostate cancer in biopsy-na\u00efve men","volume":"2","author":"Boesen","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.07.001_b0160","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.euo.2020.08.014","article-title":"Combined use of prostate-specific antigen density and magnetic resonance imaging for prostate biopsy decision planning: a retrospective multi-institutional study using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD)","volume":"4","author":"Falagario","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.07.001_b0165","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.euo.2023.03.009","article-title":"An evaluation of screening pathways using a combination of magnetic resonance imaging and prostate-specific antigen: results from the IP1-PROSTAGRAM study","volume":"6","author":"Eldred-Evans","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.07.001_b0170","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3348\/kjr.2024.1024","article-title":"Prostate cancer screening with MRI: lessons learned from repeat rounds of the GOTEBORG-2 and STHLM3-MRI trials","volume":"25","author":"Woo","year":"2024","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.euo.2025.07.001_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eururo.2022.02.021","article-title":"Is it PRIME time for biparametric magnetic resonance imaging in prostate cancer diagnosis?","volume":"82","author":"Ng","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.07.001_b0180","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4081\/aiua.2022.2.160","article-title":"Cost-effectiveness analysis of short biparametric magnetic resonance imaging protocol in men at risk of prostate cancer","volume":"94","author":"Faccioli","year":"2022","journal-title":"Arch Ital Urol Androl"},{"key":"10.1016\/j.euo.2025.07.001_b0185","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.24.32393","article-title":"Updating PI-RADS version 2.1\u2014point: the time is now!","volume":"224","author":"Barrett","year":"2025","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.euo.2025.07.001_b0190","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-070280","article-title":"Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol","volume":"13","author":"Asif","year":"2023","journal-title":"BMJ Open"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125001932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125001932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:35:50Z","timestamp":1778898950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931125001932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2588931125001932"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2025.07.001","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fast Biparametric Versus Multiparametric Magnetic Resonance Imaging for Triage of Men with Elevated Prostate-specific Antigen: The PRO-TRIAGE Prospective Comparative Trial","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2025.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}